Ashland Inc.
Description
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
About
CEO
Mr. Guillermo Novo
Employees
3,200
Instrument type
Common Stock
Sector
Basic Materials
Industry
Specialty Chemicals
MIC code
XNYS
Address
8145 Blazer Drive, Wilmington, DE 19808, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Jan 27, 2026 | — | — | — | — |
| Nov 5, 2025 | — | — | — | — |
| Aug 4, 2025 | — | — | — | — |
| Apr 28, 2025 | — | — | — | — |
| Jan 29, 2025 | 0.18 | 0.28 | 0.10 | 55.56% |
Earnings estimate
|
Current Quarter
(Mar 2025)
|
Next Quarter
(Jun 2025)
|
Current Year
(Sep 2025)
|
Next Year
(Sep 2026)
|
|
|---|---|---|---|---|
| Number of analysts | 7 | 7 | 9 | 9 |
| Average estimate | 1.22 | 1.51 | 4.36 | 5.35 |
| Low estimate | 1.12 | 1.41 | 4.10 | 4.70 |
| High estimate | 1.33 | 1.57 | 4.67 | 6.00 |
| Last year EPS | 1.27 | 1.49 | 4.45 | 4.36 |
[stock_revenue_estimate]
Growth estimates
Current qtr (Mar 2025)
-3.930%
Next qtr. (Jun 2025)
1.130%
Current year (Sep 2025)
-2.130%
Next year (Sep 2026)
22.800%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fiscal date | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Total reported revenue | 2.11B | 2.19B | 2.39B | 2.11B | 2.02B |
| Cost of revenue | 1.50B | 1.52B | 1.56B | 1.44B | 1.42B |
| Gross profit | 618.00M | 668.00M | 830.00M | 670.00M | 599.00M |
| Operating expense | |||||
| Research & development | 55.00M | 51.00M | 55.00M | 50.00M | 56.00M |
| Selling general and admin | 404.00M | 365.00M | 393.00M | 358.00M | 400.00M |
| Other operating expenses | — | — | — | — | -8.00M |
| Operating income | 83.00M | 159.00M | 288.00M | 172.00M | 59.00M |
| Non operating interest income | |||||
| Income | 10.00M | 12.00M | 4.00M | 1.00M | 1.00M |
| Expense | 53.00M | 54.00M | 62.00M | 69.00M | 88.00M |
| Other income expense | -62.00M | 46.00M | -20.00M | 51.00M | -487.00M |
| Pretax income | -24.00M | 160.00M | 206.00M | 135.00M | -577.00M |
| Tax provision | -223.00M | -8.00M | 25.00M | -38.00M | -22.00M |
| Net income | 169.00M | 178.00M | 927.00M | 220.00M | -508.00M |
| Basic EPS | 3.60 | 3.36 | 17.17 | 3.86 | -8.33 |
| Diluted EPS | 3.36 | 3.31 | 16.41 | 3.59 | -8.39 |
| Basic average shares | 47.00M | 53.00M | 54.00M | 57.00M | 61.00M |
| Diluted average shares | 47.00M | 53.00M | 54.00M | 57.00M | 61.00M |
| EBITDA | 343.00M | 409.00M | 553.00M | 404.00M | 244.00M |
| Net income from continuing op. | 199.00M | 168.00M | 181.00M | 173.00M | -508.00M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fiscal date | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
| Total assets | 5.65B | 5.94B | 6.21B | 6.61B | 6.88B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 300.00M | 417.00M | 646.00M | 210.00M | 454.00M |
| Other short term investments | — | — | — | — | — |
| Accounts receivable | 243.00M | 338.00M | 402.00M | 369.00M | 437.00M |
| Other receivables | — | — | — | — | — |
| Inventory | 545.00M | 626.00M | 629.00M | 473.00M | 506.00M |
| Prepaid assets | — | — | — | — | — |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | 597.00M | 63.00M |
| Hedging assets | — | — | — | — | — |
| Other current assets | 107.00M | 125.00M | 91.00M | 68.00M | 87.00M |
| Non current assets | |||||
| Properties | 114.00M | 122.00M | 107.00M | 124.00M | 126.00M |
| Land and improvements | 149.00M | 146.00M | 138.00M | 142.00M | 145.00M |
| Machinery furniture equipment | 2.51B | 2.37B | 2.32B | 2.28B | 2.22B |
| Construction in progress | 181.00M | 227.00M | 130.00M | 194.00M | 190.00M |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -2.01B | -1.84B | -1.71B | -1.64B | -1.52B |
| Goodwill | 3.52B | 3.62B | 3.59B | 3.97B | 3.63B |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | 757.00M | 892.00M | 969.00M | 1.11B | 1.02B |
| Investments and advances | 3.00M | 3.00M | 3.00M | 4.00M | 5.00M |
| Other non current assets | 874.00M | 664.00M | 695.00M | 776.00M | 1.36B |
| Total liabilities | 2.78B | 2.84B | 2.99B | 3.86B | 3.84B |
| Current liabilities | |||||
| Accounts payable | 214.00M | 210.00M | 265.00M | 236.00M | 211.00M |
| Accrued expenses | 256.00M | 208.00M | 269.00M | 251.00M | 272.00M |
| Short term debt | 20.00M | 38.00M | 19.00M | 397.00M | 302.00M |
| Deferred revenue | — | — | — | — | — |
| Tax payable | — | — | — | — | — |
| Pensions | — | — | — | — | — |
| Other current liabilities | — | — | — | 50.00M | 28.00M |
| Non current liabilities | |||||
| Long term debt | 1.45B | 1.42B | 1.36B | 1.71B | 1.69B |
| Provision for risks and charges | 69.00M | 79.00M | 127.00M | 145.00M | 214.00M |
| Deferred liabilities | 29.00M | 148.00M | 176.00M | 237.00M | 229.00M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 25.00M | 22.00M | 16.00M | 21.00M | 36.00M |
| Shareholders equity | |||||
| Common stock | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M |
| Retained earnings | 3.32B | 3.60B | 3.65B | 2.80B | 2.65B |
| Other shareholders equity | -448.00M | -503.00M | -569.00M | -372.00M | -383.00M |
| Total shareholders equity | 2.87B | 3.10B | 3.22B | 2.75B | 3.04B |
| Additional paid in capital | — | 4.00M | 135.00M | 327.00M | 769.00M |
| Treasury stock | — | — | — | — | — |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||
| Net Income | 199.00M | 168.00M | 181.00M | 173.00M | -508.00M | 505.00M | 114.00M | 28.00M | -28.00M | 309.00M | 233.00M | 683.00M | 26.00M | 414.00M | -53.00M | 78.00M | 167.00M | 230.00M | 407.00M | 2.00B | 378.00M | 94.00M | 115.00M | 406.00M | 74.00M | 290.00M | 203.00M | 288.00M | 211.00M | 24.00M | 197.00M | 142.20M | -68.30M | 145.00M | 182.10M | 86.20M |
| Depreciation | 274.00M | 243.00M | 241.00M | 244.00M | 235.00M | 277.00M | 277.00M | 265.00M | 302.00M | 306.00M | 393.00M | 356.00M | 359.00M | 299.00M | 280.00M | 329.00M | 145.00M | 133.00M | 111.00M | 100.00M | 98.00M | 204.00M | 208.00M | 250.00M | 237.00M | 228.00M | 181.00M | 348.00M | 299.00M | 487.00M | 308.00M | 304.60M | 302.10M | 278.60M | 269.40M | 279.20M |
| Deferred Taxes | -302.00M | -32.00M | -35.00M | -26.00M | -42.00M | 18.00M | -100.00M | -26.00M | -29.00M | -49.00M | -294.00M | 153.00M | -125.00M | -57.00M | -67.00M | 12.00M | 44.00M | 22.00M | -1.00M | -500.00M | 104.00M | 71.00M | -104.00M | 157.00M | 111.00M | 102.00M | 60.00M | 33.00M | -9.00M | -73.00M | 2.00M | 28.90M | -146.40M | 2.00M | -22.20M | 14.20M |
| Stock-Based Compensation | 15.00M | 22.00M | 18.00M | 15.00M | 14.00M | 21.00M | 27.00M | 20.00M | 30.00M | 30.00M | 34.00M | 30.00M | 28.00M | 16.00M | 14.00M | 9.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | -9.00M | -2.00M | 2.00M | -1.00M | -41.00M | -536.00M | -95.00M | -102.00M | -262.00M | -824.00M | -189.00M | -189.00M | 77.00M | -298.00M | 163.00M | 60.00M | 12.00M | — | -3.00M | 140.00M | 38.00M | — | -114.00M | — | — | — | — | -51.00M | 35.00M | 33.00M | 39.00M | -2.50M | 207.40M | 34.90M | 29.70M | 63.30M |
| Accounts Receivable | 96.00M | 58.00M | -23.00M | 72.00M | 2.00M | 37.00M | -42.00M | -29.00M | 77.00M | 211.00M | -16.00M | 43.00M | 9.00M | -40.00M | -128.00M | 405.00M | 10.00M | -54.00M | -76.00M | -291.00M | -149.00M | -79.00M | 110.00M | 82.00M | 68.00M | -90.00M | -54.00M | -16.00M | -60.00M | -112.00M | -153.00M | 13.00M | 36.30M | 158.40M | -267.30M | -79.00M |
| Accounts Payable | — | — | — | — | — | — | — | — | — | — | — | — | -111.00M | -65.00M | 58.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | 75.00M | -4.00M | -248.00M | 5.00M | 53.00M | -106.00M | 19.00M | -24.00M | 75.00M | -237.00M | -266.00M | -152.00M | -463.00M | -330.00M | 53.00M | 264.00M | 67.00M | -1.00M | -107.00M | -47.00M | -58.00M | -66.00M | 65.00M | -19.00M | -198.00M | -59.00M | 26.00M | 144.00M | -29.00M | -28.00M | -17.00M | 33.30M | 59.00M | 62.90M | -79.40M | -182.70M |
| Operating Cash Flow | 348.00M | 453.00M | 136.00M | 482.00M | -287.00M | 216.00M | 200.00M | 132.00M | 165.00M | -254.00M | -105.00M | 924.00M | -200.00M | -61.00M | 320.00M | 1.16B | 445.00M | 330.00M | 331.00M | 1.41B | 411.00M | 224.00M | 280.00M | 876.00M | 292.00M | 471.00M | 416.00M | 746.00M | 447.00M | 331.00M | 376.00M | 519.50M | 390.10M | 681.80M | 112.30M | 181.20M |
| Investing Activities | ||||||||||||||||||||||||||||||||||||
| Capital Expenditures | -137.00M | -159.00M | -62.00M | -100.00M | -128.00M | -138.00M | -153.00M | -163.00M | -229.00M | -219.00M | -245.00M | -259.00M | -236.00M | -187.00M | -171.00M | -127.00M | -195.00M | -154.00M | -175.00M | -180.00M | -137.00M | -105.00M | -178.00M | -196.00M | -182.00M | -320.00M | -468.00M | -435.00M | -455.00M | -444.00M | -353.00M | -293.10M | -466.40M | -408.10M | -529.70M | -440.60M |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | 26.00M | — | — | -295.00M | 9.00M | -2.00M | -5.00M | -662.00M | 19.00M | 131.00M | 92.00M | -13.00M | 21.00M | -1.93B | 41.00M | -1.97B | -103.00M | -75.00M | -183.00M | 3.17B | -5.00M | -5.00M | -15.00M | -91.00M | -590.00M | — | — | — | — | — | — | — | — | — | — | — |
| Purchase of Investments | -53.00M | -47.00M | -87.00M | -149.00M | -21.00M | -350.00M | -29.00M | -22.00M | -15.00M | -322.00M | -15.00M | — | — | — | — | — | -435.00M | -484.00M | -824.00M | -402.00M | — | — | — | — | — | -235.00M | -215.00M | -248.00M | -455.00M | -725.00M | -335.00M | -451.40M | -465.30M | -327.40M | -174.40M | -33.60M |
| Sale of Investments | 53.00M | 47.00M | 87.00M | 150.00M | 21.00M | 354.00M | 27.00M | 24.00M | 19.00M | 333.00M | — | — | 10.00M | 11.00M | 150.00M | 73.00M | 315.00M | 680.00M | 876.00M | 1.00M | — | — | — | — | — | 311.00M | 308.00M | 216.00M | 490.00M | 704.00M | 335.00M | 440.20M | 433.20M | 306.00M | 164.70M | — |
| Investing Cash Flow | -51.00M | -109.00M | -102.00M | -367.00M | -85.00M | -111.00M | -174.00M | -798.00M | -177.00M | -391.00M | -183.00M | -272.00M | -205.00M | -2.10B | 20.00M | -2.12B | -418.00M | -10.00M | -286.00M | 2.60B | -119.00M | -97.00M | -167.00M | -274.00M | -701.00M | -198.00M | -585.00M | -440.00M | -395.00M | -781.00M | -356.00M | -305.90M | -576.40M | -506.40M | -464.80M | -419.20M |
| Financing Activities | ||||||||||||||||||||||||||||||||||||
| Long-Term Debt Issuance | — | — | — | 450.00M | 804.00M | — | — | 1.10B | — | 1.10B | — | 2.32B | 502.00M | 2.91B | 334.00M | 2.63B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-Term Debt Payments | — | — | -250.00M | -427.00M | -826.00M | -797.00M | -311.00M | -932.00M | -1.25B | -635.00M | -11.00M | -2.65B | -1.02B | -1.51B | -732.00M | -2.04B | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Financing Charges | -5.00M | -11.00M | -11.00M | -13.00M | -18.00M | -10.00M | -12.00M | -30.00M | -10.00M | -9.00M | 12.00M | -25.00M | 6.00M | -78.00M | -8.00M | 1.00M | 1.00M | 9.00M | 6.00M | 20.00M | 3.00M | — | — | — | — | — | — | — | 11.00M | 22.00M | — | — | -100,000 | — | -11.20M | -100,000 |
| Financing Cash Flow | -479.00M | -371.00M | -896.00M | -426.00M | 9.00M | -1.15B | -368.00M | 136.00M | -1.30B | -42.00M | -1.03B | -628.00M | -317.00M | 1.21B | -393.00M | 383.00M | -65.00M | -1.00B | -459.00M | -44.00M | 34.00M | -73.00M | -107.00M | -110.00M | -162.00M | -155.00M | -120.00M | -54.00M | -63.00M | -15.00M | -62.00M | 228.80M | -58.20M | -62.20M | -81.60M | -86.30M |
| Other Cash Details | ||||||||||||||||||||||||||||||||||||
| End Cash Position | 300.00M | 417.00M | 646.00M | 210.00M | 454.00M | 232.00M | 294.00M | 566.00M | 1.02B | 1.26B | 1.39B | 346.00M | 523.00M | 737.00M | 417.00M | 352.00M | 886.00M | 897.00M | 1.82B | 985.00M | 243.00M | 223.00M | 90.00M | 236.00M | 67.00M | 110.00M | 34.00M | 250.00M | — | — | — | — | — | — | — | — |
| Income Tax Paid | 53.00M | 63.00M | 406.00M | 1.00M | 91.00M | 67.00M | 77.00M | 79.00M | 108.00M | 226.00M | 88.00M | 69.00M | 88.00M | 97.00M | 86.00M | 49.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | 52.00M | 53.00M | 56.00M | 62.00M | 77.00M | 124.00M | 126.00M | 132.00M | 162.00M | 149.00M | 154.00M | 182.00M | 202.00M | 109.00M | 118.00M | 198.00M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 274.00M | 73.00M | -326.00M | 455.00M | 70.00M | 94.00M | 140.00M | 215.00M | 447.00M | 113.00M | 395.00M | 469.00M | 112.00M | 44.00M | 314.00M | 853.00M | 265.00M | 41.00M | 170.00M | -191.00M | 49.00M | 417.00M | 25.00M | 710.00M | 212.00M | 70.00M | -157.00M | 615.00M | 124.00M | 56.00M | 78.00M | -182.70M | -106.20M | 27.80M | -183.60M | -372.40M |
Error: Invalid format in Holders JSON file.
Article
Ashland's Earnings Outpace Estimates, Revenues Miss in Q1
Organic sales volume growth in ASH's Personal Care, Specialty Additives and Intermediates segments largely offset lower volumes in Life Sciences in Q1.
Jan 30, 2025
Article
Ashland Inc. (ASH) Q1 2025 Earnings Call Transcript
Ashland Inc. (NYSE:ASH ) Q1 2025 Earnings Conference Call January 29, 2025 9:00 AM ET Company Participants William Whitaker - VP, Finance and Director, IR Guillermo Novo - Chair and CEO Kevin Willis - CFO Alessandra Faccin - SVP and GM, Life Sciences and Intermediates Jim Minicucci - SVP and GM, Personal Care Dago Caceres - SVP and GM, Specialty Additives Conference Call Participants Michael Sison - Wells Fargo Chris Parkinson - Wolfe Research John Roberts - Mizuho David Begleiter - Deutsche Bank Jeff Zekauskas - JPMorgan Mike Harrison - Seaport Research Partners Bhavesh Lodaya - BMO Capital Markets Josh Spector - UBS Operator Good day and thank you for standing by. Welcome to the Ashland Inc. First Quarter 2025 Earnings Conference Call.
Jan 30, 2025
Article
New Strong Sell Stocks for January 29th
ARCAY, ASH and DNKEY have been added to the Zacks Rank #5 (Strong Sell) List on January 29, 2024.
Jan 29, 2025
